Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

Delayed Quote. Delayed  - 09/30 10:00:00 pm
39.29 USD   +0.64%
09/27 NATUS MEDICAL : Enters into Agreement to Acquire GN Otometrics; Prov..
09/26 GN STORE NORD A : Otometrics to be Sold to Natus Medical
09/26 Natus Enters into Agreement to Acquire GN Otometrics; Provides Q3..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CEST

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
InvestorRelations@Natus.com


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
09/27 NATUS MEDICAL : Enters into Agreement to Acquire GN Otometrics; Provides Q3 Reve..
09/26 GN STORE NORD A/S : Otometrics to be Sold to Natus Medical
09/26 NATUS MEDICAL INC : Entry into a Material Definitive Agreement, Termination of a..
09/26 Natus Enters into Agreement to Acquire GN Otometrics; Provides Q3 Revenue Upd..
09/25 NATUS MEDICAL : Divestment of GN Otometrics and strategic partnership with Natus..
09/23 NATUS MEDICAL : Announces Appointment of Barbara R. Paul, M.D. to its Board of D..
09/22 Natus Medical Announces Appointment of Barbara R. Paul, M.D. to its Board of ..
09/22 NATUS MEDICAL INC : Financial Statements and Exhibits (form 8-K)
09/13 GLOBAL INTRAPARTUM MONITORS MARKET 2 : Allen Medical, Analogic, Med-Electronics,..
09/08 NATUS MEDICAL : The Uncommon Common Sense Behind Concussions
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/29 INSIDERINSIGHTS.COM DAILY ROUND UP 9 : Cyh, bjri, baby, hy
09/26 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/06 Natus Medical receives $20M payment from Venezuela under supply contract with..
07/20 Natus Medical's (BABY) CEO Jim Hawkins on Q2 2016 Results - Earnings Call Tra..
07/20 Natus Medical Q2 revenues up 5%; Non-GAAP EPS up 15%; updates guidance
Advertisement
Financials ($)
Sales 2016 378 M
EBIT 2016 66,3 M
Net income 2016 42,5 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 30,38
P/E ratio 2017 26,11
Capi. / Sales 2016 3,40x
Capi. / Sales 2017 3,23x
Capitalization 1 286 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 46,5 $
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy CFO, Principal Financial & Accounting Officer, SVP
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC-18.75%1 286
THERMO FISHER SCIENTIF..10.02%61 529
BOSTON SCIENTIFIC CORP..26.36%31 705
PHILIPS11.84%28 018
INTUITIVE SURGICAL, IN..31.83%27 715
ILLUMINA, INC.-8.02%25 884
More Results